Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 16, 2017 07:15 ET | Source: iBio, Inc.

iBio Announces Manufacturing Collaboration with Aethlon Medical

NEW YORK, Oct. 16, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the...
October 02, 2017 08:30 ET | Source: iBio, Inc.

iBio Appoints James Abbey, Ph.D. as Vice President of Strategic Business Development

NEW YORK, Oct. 02, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced today the...
September 20, 2017 08:00 ET | Source: iBio, Inc.

iBio, Inc. Intellectual Property Update

NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, provided an update...
September 19, 2017 17:55 ET | Source: iBio, Inc.

iBio Makes NYSE MKT Section 610(b) Public Announcement

NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) – iBio, a leader in developing plant-based biopharmaceuticals, today announced that, as previously disclosed in its...
September 18, 2017 08:00 ET | Source: iBio, Inc.

iBio and TheoremDx Collaborate to Develop Proteins for Rapid Diagnostics Testing Products

NEW YORK, Sept. 18, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) – iBio, with its subsidiary, iBio CDMO LLC in Bryan/College Station, Texas ("iBio CDMO"), has partnered with TheoremDx,...
July 24, 2017 08:30 ET | Source: iBio, Inc.

iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital

NEW YORK, July 24, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE MKT:IBIO) (“iBio”), a leader in developing plant-based biopharmaceuticals, announced today that it has entered into a $16 million common...
June 05, 2017 08:30 ET | Source: iBio, Inc.

iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference

NEW YORK, June 05, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE MKT:IBIO), a leader in developing plant-based biopharmaceuticals, announced today that Barry Holtz, PhD, President of iBio CMO LLC is...
May 04, 2017 16:01 ET | Source: iBio, Inc.

iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting

NEW YORK, NY--(Marketwired - May 4, 2017) - iBio, Inc. (NYSE MKT: IBIO), a leader in developing plant-based biopharmaceuticals, announced today that it provided a corporate update at its Annual...
January 27, 2017 08:30 ET | Source: iBio, Inc.

Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action

NEW YORK, NY--(Marketwired - Jan 27, 2017) - iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider...
November 21, 2016 08:31 ET | Source: iBio, Inc.

Another iBio Plague Vaccine Patent Issues

NEW YORK, NY--(Marketwired - Nov 21, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue of...